Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing v3.2.0. No substantive study details or layout changes are apparent.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site-wide funding/operating status notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedVisual/layout updates across the page, including header spacing and section dividers, with no changes to core study content, eligibility criteria, enrollment numbers, or dates. The page's substantive information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.SummaryDifference5%

- Check78 days agoChange DetectedSummary: The page version is upgraded to v3.1.0 and several pharmaceutical categories (Placebos, Therapeutics, Pharmaceutical Preparations) are removed, indicating a scope revision rather than new core content.SummaryDifference0.4%

- Check92 days agoChange DetectedUpdated core content: Revision changed from v3.0.1 to v3.0.2. Removed the 'Back to Top' element (minor UI change).SummaryDifference0.3%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.